Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.43
30.04.23
-
30.04.24
-47.00%
01.05.24

StockNews.com 
30.04.23 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.55
22.04.23
-
22.04.24
-76.33%
23.04.24

StockNews.com 
22.04.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.41
22.04.23
-
22.04.24
-43.90%
23.04.24

StockNews.com 
22.04.23 50%
sell
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€13.20
18.04.23
-
18.04.24
-1.52%
27.04.23

Growths slower than the competition
Higher risks for its business
fenjal 
18.04.23 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.34
15.04.23
-
15.04.24
-12.16%
29.04.23

michaelkr 
15.04.23 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.28
14.04.23
€14.00
14.05.23
-24.11%
15.05.23

Nico 
14.04.23 87%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.57
04.04.23
-
04.04.24
-15.01%
14.04.23

quelbe60 
04.04.23 50%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.80
03.04.23
-
03.04.27
-12.14%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
03.04.23 50%
sell
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.78
03.04.23
-
03.04.24
0.20%
15.04.23

kugelmann 
03.04.23 0%
sell
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€10.25
31.03.23
-
31.03.24
-4.55%
01.04.23

kugelmann 
31.03.23 0%
buy
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.46
29.03.23
€25.81
29.03.24
-22.36%
30.03.24

HC Wainwright 
29.03.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.87
24.03.23
-
24.03.24
12.58%
18.05.23

Could be very worthwhile Investment >20% year
quelbe60 
24.03.23 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.77
21.03.23
-
21.03.24
-7.32%
02.04.23

Could be very worthwhile Investment >20% year
thomasw 
21.03.23 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.75
21.03.23
€2.50
21.03.24
-73.16%
22.03.24

krebskrebs 
21.03.23 50%
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.30
20.03.23
-
20.03.24
6.18%
23.03.23

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
me8 
20.03.23 0%
sell
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.52
19.03.23
-
19.03.24
-24.05%
20.03.24

StockNews.com 
19.03.23 50%
buy
Edesa Biotech Inc

Start price
Target price
Perf. (%)
€0.99
15.03.23
€15.12
15.03.24
-60.91%
16.03.24

HC Wainwright 
15.03.23 50%
sell
AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€2.50
11.03.23
-
11.03.24
-31.76%
12.03.24

StockNews.com 
11.03.23 50%
sell
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.22
11.03.23
€4.60
11.03.24
18.48%
19.05.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
11.03.23 50%
sell
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.93
11.03.23
€0.30
11.03.24
-77.19%
08.07.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
geldnutzer 
11.03.23 50%
buy
Oncolytics Biotech

Start price
Target price
Perf. (%)
€1.61
06.03.23
€4.69
06.03.24
-
07.03.24

Canaccord Genuity Group Inc. 
06.03.23 50%
buy
Oncolytics Biotech

Start price
Target price
Perf. (%)
€1.61
06.03.23
-
06.03.24
-
07.03.24

Cantor Fitzgerald 
06.03.23 50%
sell
Nymox Pharmaceutical Corp.

Start price
Target price
Perf. (%)
€0.36
05.03.23
-
05.03.24
-35.75%
06.03.24

StockNews.com 
05.03.23 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.16
04.03.23
-
04.03.24
-10.37%
17.03.23

michaelkr 
04.03.23 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
01.03.23
€14.00
-
02.03.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
01.03.23 50%